Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan-based sequential versus triple therapy for early adult Helicobacter pylori infection
jRCTs031180209Completed
- Sponsor
- Yokohama City University
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of vonoprazan, amoxicillin, metronidazole and sitafloxacin in Helicobacter pylori infection (2 arms), sponsored by Yokohama City University. Primary endpoint: Eradication rate. Started Jan 2019; status: completed.
02
Drugs
vonoprazanamoxicillinmetronidazolesitafloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on jRCTs031180209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180209.